Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MS and NMO: Partners No More.
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
Neuroprotective effects of riluzole in neurotrauma models: a review.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Guillain-Barré syndrome in Colombia: where do we stand now?
MYRAC Rx
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.
Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique.
Slowing of brain atrophy and reductions in new multiple sclerosis lesions sustained at three years in patients treated with Genzyme's LemtradaTM
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle.
Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming.
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
Severe haematological complications during treatment with natalizumab.
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
The initiation and prevention of multiple sclerosis.

Pages